HIF1A and cardiovascular disorder: These findings establish a mechanistic bridge between cardiovascular disease and cognitive dysfunction and reveal microglial HIF-1α signaling as a tractable therapeutic strategy for preventing cognitive decline in cardiometabolic disease.